First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors

Albiruni R. Abdul Razak, Morten Mau-Soerensen, Nashat Y. Gabrail, John F. Gerecitano, Anthony F. Shields, Thaddeus J. Unger, Jean R. Saint-Martin, Robert Carlson, Yosef Landesman, Dilara McCauley, Tami Rashal, Ulrik Lassen, Richard Kim, Lee Anne Stayner, Mansoor R. Mirza, Michael Kauffman, Sharon Shacham, Amit Mahipal

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint Dive into the research topics of 'First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences